These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23124885)

  • 1. Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance.
    Zhao F; Lam EW
    Front Med; 2012 Dec; 6(4):376-80. PubMed ID: 23124885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance.
    Gomes AR; Zhao F; Lam EW
    Chin J Cancer; 2013 Jul; 32(7):365-70. PubMed ID: 23706767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance.
    Nestal de Moraes G; Bella L; Zona S; Burton MJ; Lam EW
    Curr Drug Targets; 2016; 17(2):164-77. PubMed ID: 25418858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO and FOXM1 in cancer: the FOXO-FOXM1 axis shapes the outcome of cancer chemotherapy.
    Wilson MS; Brosens JJ; Schwenen HD; Lam EW
    Curr Drug Targets; 2011 Aug; 12(9):1256-66. PubMed ID: 21443467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer.
    McGovern UB; Francis RE; Peck B; Guest SK; Wang J; Myatt SS; Krol J; Kwok JM; Polychronis A; Coombes RC; Lam EW
    Mol Cancer Ther; 2009 Mar; 8(3):582-91. PubMed ID: 19276163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance.
    Yao S; Fan LY; Lam EW
    Semin Cancer Biol; 2018 Jun; 50():77-89. PubMed ID: 29180117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting forkhead box transcription factors FOXM1 and FOXO in leukemia (Review).
    Zhu H
    Oncol Rep; 2014 Oct; 32(4):1327-34. PubMed ID: 25175498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1: From cancer initiation to progression and treatment.
    Koo CY; Muir KW; Lam EW
    Biochim Biophys Acta; 2012 Jan; 1819(1):28-37. PubMed ID: 21978825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer.
    Karadedou CT; Gomes AR; Chen J; Petkovic M; Ho KK; Zwolinska AK; Feltes A; Wong SY; Chan KY; Cheung YN; Tsang JW; Brosens JJ; Khoo US; Lam EW
    Oncogene; 2012 Apr; 31(14):1845-58. PubMed ID: 21860419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells.
    Madureira PA; Varshochi R; Constantinidou D; Francis RE; Coombes RC; Yao KM; Lam EW
    J Biol Chem; 2006 Sep; 281(35):25167-76. PubMed ID: 16809346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.
    Li X; Yao R; Yue L; Qiu W; Qi W; Liu S; Yao Y; Liang J
    J Cell Mol Med; 2014 May; 18(5):811-23. PubMed ID: 24628949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.
    Ahn H; Sim J; Abdul R; Chung MS; Paik SS; Oh YH; Park CK; Jang K
    J Korean Med Sci; 2015 Apr; 30(4):390-7. PubMed ID: 25829806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy: tailoring cancer treatment.
    Yan M; Liu QQ
    Chin J Cancer; 2013 Jul; 32(7):363-4. PubMed ID: 23823626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXM1: A small fox that makes more tracks for cancer progression and metastasis.
    Khan MA; Khan P; Ahmad A; Fatima M; Nasser MW
    Semin Cancer Biol; 2023 Jul; 92():1-15. PubMed ID: 36958703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.
    Khongkow P; Gomes AR; Gong C; Man EP; Tsang JW; Zhao F; Monteiro LJ; Coombes RC; Medema RH; Khoo US; Lam EW
    Oncogene; 2016 Feb; 35(8):990-1002. PubMed ID: 25961928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FoxM1 as a novel therapeutic target for cancer drug therapy.
    Xu XS; Miao RC; Wan Y; Zhang LQ; Qu K; Liu C
    Asian Pac J Cancer Prev; 2015; 16(1):23-9. PubMed ID: 25640357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of AG1478 on the expression of FOXM1 gene via FOXO3a in non-small cell lung cancer cells].
    Gong XD; Yuan HH; Wang JY; Guo YH; Shi J; Jiang B
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):572-8. PubMed ID: 24314213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia.
    Buchner M; Park E; Geng H; Klemm L; Flach J; Passegué E; Schjerven H; Melnick A; Paietta E; Kopanja D; Raychaudhuri P; Müschen M
    Nat Commun; 2015 Mar; 6():6471. PubMed ID: 25753524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.